Drug Profile
Staphylococcus aureus vaccine conjugate pentavalent - GlaxoSmithKline
Alternative Names: PentaStaph; StaphVAX-PentavalentLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Nabi Biopharmaceuticals
- Developer Biota Pharmaceuticals; GlaxoSmithKline
- Class Bacterial vaccines; Conjugate vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gram-positive infections; Staphylococcal infections